Bibliotecas PUC-SP - Busca Integrada

Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells: The Adipokine Receptor CAP1 Matters

Por Malin Bergqvist, Karin Elebro, Karin Elebro, Signe Borgquist, Signe Borgquist, Signe Borgquist, Ann H. Rosendahl
Publicado no Frontiers in Oncology (2021-03-01)

Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer: significance of the BIG 1–98 and ATAC trial data

Por Sixten Harborg, Signe Borgquist
Publicado no Discover Oncology (2025-07-01)

Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis

Por Ann H. Rosendahl, Malin Bergqvist, Barbara Lettiero, Siker Kimbung, Signe Borgquist, Signe Borgquist
Publicado no Frontiers in Endocrinology (2018-11-01)

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment

Por Christopher Godina, Erik Ottander, Helga Tryggvadottir, Signe Borgquist, Signe Borgquist, Karolin Isaksson, Helena Jernström
Publicado no Frontiers in Oncology (2020-02-01)

Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer

Por Jonas Busk Holm, Ann H. Rosendahl, Signe Borgquist
Publicado no Cancers (2021-12-01)

Statin use and breast cancer survival – a Swedish nationwide study

Por Signe Borgquist, Per Broberg, Jasaman Tojjar, Håkan Olsson
Publicado no BMC Cancer (2019-01-01)

FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics

Por Öykü Boraka, Marie Klintman, Johan Vallon-Christersson, Sophia Zackrisson, Per Hall, Per Hall, Signe Borgquist, Signe Borgquist, Ann H. Rosendahl
Publicado no Frontiers in Oncology (2023-07-01)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

Por Sofie Björner, Ann H. Rosendahl, Maria Simonsson, Andrea Markkula, Karin Jirström, Signe Borgquist, Signe Borgquist, Carsten Rose, Christian Ingvar, Helena Jernström
Publicado no Frontiers in Endocrinology (2017-11-01)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study

Por Ann H. Rosendahl, Sofie Björner, Maria Ygland Rödström, Karin Jirström, Signe Borgquist, Signe Borgquist, Christian Ingvar, Michael N. Pollak, Helena Jernström
Publicado no Frontiers in Oncology (2021-03-01)

Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality

Por Malte Sandsveden, Signe Borgquist, Ann H. Rosendahl, Jonas Manjer
Publicado no Breast Cancer Research (2021-12-01)

Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study

Por Kasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen, Signe Borgquist
Publicado no Lipids in Health and Disease (2022-07-01)

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study

Por Maria Inasu, Maria Feldt, Helena Jernström, Signe Borgquist, Sixten Harborg
Publicado no Breast (2022-02-01)

Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer

Por Malin Bergqvist, Karin Elebro, Malte Sandsveden, Signe Borgquist, Ann H. Rosendahl
Publicado no Breast Cancer Research (2020-06-01)

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis

Por Linn Nilsson, Linn Nilsson, Linn Nilsson, Emma Sandén, Somayeh Khazaei, Helga Tryggvadottir, Björn Nodin, Karin Jirström, Signe Borgquist, Signe Borgquist, Karolin Isaksson, Karolin Isaksson, Helena Jernström
Publicado no Frontiers in Oncology (2020-07-01)

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Por Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson, Signe Borgquist
Publicado no BMC Cancer (2019-12-01)

Zinc and Breast Cancer Survival: A Prospective Cohort Study of Dietary Intake and Serum Levels

Por Ylva Bengtsson, Kamil Demircan, Ann H. Rosendahl, Signe Borgquist, Malte Sandsveden, Jonas Manjer
Publicado no Nutrients (2022-06-01)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer

Por Maria Inasu, Pär-Ola Bendahl, Mårten Fernö, Per Malmström, Signe Borgquist, Siker Kimbung
Publicado no npj Breast Cancer (2021-09-01)

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study

Por Helga Tryggvadottir, Emma Sandén, Sofie Björner, Alessandra Bressan, Maria Ygland Rödström, Somayeh Khazaei, Dean P. Edwards, Björn Nodin, Karin Jirström, Karolin Isaksson, Karolin Isaksson, Signe Borgquist, Signe Borgquist, Helena Jernström
Publicado no Frontiers in Oncology (2021-05-01)

Up-regulation of intra-tumour LDLR gene expression is associated with statin treatment and better prostate cancer prognosis

Por Kia Eistrup Fonfara, Jacob Fredsøe, Benedicte Ulhøi, Signe Borgquist, Michael Borre, Karina Dalsgaard Sørensen
Publicado no Acta Oncologica (2025-10-01)

Feasibility of an exercise program in endocrine-treated metastatic breast cancer patients with overweight: protocol for the FEMA study

Por May Wissing, Pernille Skovlund, Susanne Drysdale, Ali Amidi, Robert Zachariae, Tinne Laurberg, Signe Borgquist
Publicado no Pilot and Feasibility Studies (2025-04-01)